Help | RSS Feed



Trillium Therapeutics Inc. (NASD:TRIL) Seasonal Chart

Trillium Therapeutics Inc. (NASD:TRIL) Seasonality

TRIL Relative to the S&P 500
TRIL Relative to the S&P 500

TRIL Relative to the Sector
TRIL Relative to the Sector

Monthly Seasonal Trillium Therapeutics Inc. (NASD:TRIL)

Seasonal Chart Analysis

Analysis of the Trillium Therapeutics Inc. (NASD:TRIL) seasonal charts above shows that a Buy Date of July 19 and a Sell Date of November 23 has resulted in a geometric average return of 21.75% above the benchmark rate of the S&P 500 Total Return Index over the past 6 years. This seasonal timeframe has shown positive results compared to the benchmark in 4 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 6 years by an average of 45.77% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 6 years of data is available for shares of TRIL, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore